Company profile · Warsaw, Poland

Pratia Poland

Research Site Network Operations, Hybrid Trials, and Decentralized Clinical Execution · Multi-country site-network platform

Pratia Poland runs site network operations, hybrid trials, and decentralized trial delivery in Warsaw, Poland.

Lead
Łukasz Bęczkowski (verified ↗)
Address
Warsaw, Poland (source ↗)
Compliance
GCP, EMA, FDA and GDPR operating framework
Last reviewed
14 Mar 2026 (3mo ago)
Scale
Multi-country site-network platform
Capabilities
Site Network Operations · Hybrid Trials · Decentralized Trial Delivery
Founded
2016
Headcount
501-1000
LinkedIn
Company page (open ↗)
Site and address
Clinical profileSTATUS: VERIFIED MARCH 2026

Łukasz Bęczkowski

Chief Operating Officer

Check official leadership source
Full addressWarsaw, Poland
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source

Official Pratia expansion release confirming the Warsaw operating node in Poland.

Open source
Operating profile

Multi-country site-network platform

Warsaw, Poland. Research Site Network Operations, Hybrid Trials, and Decentralized Clinical Execution. Review completed on 14 Mar 2026.

2026 technical specializationResearch Site Network Operations, Hybrid Trials, and Decentralized Clinical Execution
Core capabilities
Site Network OperationsHybrid TrialsDecentralized Trial DeliveryInvestigator Access
Governance

EU and local clinical-trial oversight

GCP, EMA, FDA and GDPR operating framework, Hybrid and decentralized trial controls

Editorial note

Research Site Network Operations, Hybrid Trials, and Decentralized Clinical Execution

Pratia is published with the current public operating lead, Łukasz Bęczkowski, rather than inventing a separate Poland CEO that the company does not publicly disclose.

Editorial note

Pratia is published with the current public operating lead, Łukasz Bęczkowski, rather than inventing a separate Poland CEO that the company does not publicly disclose.

FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026Last reviewed: 14 March 2026
Capabilities

Core capabilities

Primary declared technical activities and areas of operating focus.

Site Network Operations
Hybrid Trials
Decentralized Trial Delivery
Investigator Access
Verification source dossier

Verification source dossier

Official source set used to support leadership, physical-site, certification, and watch-note evidence.

Leadership evidencePratia official leadership profile for Łukasz Bęczkowski.Source origin: pratia.comOpen source
Supporting evidencePratia January 2025 Warsaw expansion release.Source origin: pratia.comOpen source
Physical-site evidenceOfficial Pratia expansion release confirming the Warsaw operating node in Poland.Source origin: pratia.comOpen source
Infrastructure

Declared infrastructure

eCTMS and site-network systems
Hybrid-trial workflows
Investigator network infrastructure
Regulatory posture

Quality system coverage

GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.

GMP
REVIEW IN PROGRESS 2026
GLP
REVIEW IN PROGRESS 2026
ISO-13485
REVIEW IN PROGRESS 2026
FDA-Inspected
REVIEW IN PROGRESS 2026
Verification history

Verification history

14 Mar 2026: Executive identity confirmed via official management disclosure.
14 Mar 2026: Full trust review completed.
FAQ

Frequently asked questions

Where is Pratia Poland located?
Pratia Poland operates from Warsaw, Poland, Warsaw, Poland.
Who runs Pratia Poland?
Pratia Poland is led by Łukasz Bęczkowski, Chief Operating Officer. Verified 14 Mar 2026.
What certifications does Pratia Poland hold?
Pratia Poland is documented under GCP, EMA, FDA and GDPR operating framework.
What does Pratia Poland do?
Pratia Poland runs site network operations, hybrid trials, and decentralized trial delivery in Warsaw, Poland. Core capabilities: Site Network Operations, Hybrid Trials, Decentralized Trial Delivery, Investigator Access.
Editorial context

Related technical briefs

Briefs that name Warsaw as a covered market or city.